Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

  •   Table of Contents

Download Guidelines

Appendix A: Pediatric Antiretroviral Drug Information

Overview

Nucleoside and Nucleotide Analogue Reverse Transcriptase Inhibitors (NRTIs)

Abacavir
Didanosine
Emtricitabine
Lamivudine
Stavudine
Tenofovir alafenamide
Tenofovir disoproxil fumarate
Zidovudine

Non-Nucleoside Analogue Reverse Transcriptase Inhibitors (NNRTIs)

Efavirenz
Etravirine
Nevirapine
Rilpivirine

Protease Inhibitors (PIs)

Atazanavir
Darunavir
Fosamprenavir
Indinavir
Lopinavir/Ritonavir
Nelfinavir
Saquinavir
Tipranavir

Entry and Fusion Inhibitors

Enfuvirtide
Maraviroc

Integrase Inhibitors (INSTIs)

Bictegravir
Dolutegravir
Elvitegravir
Raltegravir

Pharmacokinetic Enhancers

Cobicistat
Ritonavir

Download Guidelines